from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2299c/htpG

LFCtreatmentdescriptionclass of inhibitor

1.585

Amikacinug/mL Amikacintranslation

2.297

Cap5-10ug/mL Capreomycintranslation

1.667

Rox10-50 ug/mL Roxithromycintranslation

0.829

SM2-5 ug/mL Streptomycintranslation

1.234

Tet5-10 ug/mL Tetracyclinetranslation

-0.357

Rif0.2-5ug/mL Rifampicintranscription

-0.426

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.948

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.028

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.411

CPZ10-50 ug/mL Chlorpromazinerespiration

0.947

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.099

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.679

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.158

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-1.794

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.661

Econazole10-24 ug/mL Econazole (azole drug)respiration

-1.407

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.299

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.665

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.516

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.502

KCN5-20 ug/mL Potassium cyaniderespiration

-0.523

NaN30.2-2 mM Sodium aziderespiration

1.083

Nigericin50 uM Nigericinrespiration

-0.569

TRC10-150 ug/mL Triclosanrespiration

0.461

TRZ10-25 ug/mL Thioridazinerespiration

-0.637

Valinomycin0.5-10 uM Valinomycinrespiration

1.235

ZnSO42 mM ZnSO4respiration

-1.030

menadione6-10 ug/mL Menadionerespiration

-0.178

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.802

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.286

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.599

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.165

NRP_1Non-replicating persistence stage 1dosRassociated

0.508

Amp0.2mg/mL AmpicillincellWall

0.402

Cephalexin20-100 ug/mL CephalexincellWall

0.966

Cerulenin0.32-5 ug/mL CerulenincellWall

0.631

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.356

EMB10-20 ug/mL EthambutolcellWall

0.564

Eta12-40 ug/mL EthionamidecellWall

0.238

INH0.2-0.4 ug/mL IsoniazidcellWall

0.419

TLM0.1-0.2 mg/mL ThiolactomycincellWall

1.270

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

1.096

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.841

BZA0.12 mg/mL BenzamidearomaticAmides

-1.210

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-1.015

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.207

H2O24 mM hydrogen peroxideDNAdamaging

0.087

Levo10 ug/mL LevofloxacinDNAdamaging

0.835

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.918

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.959

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.356

UVUV-irradiationDNAdamaging

0.116

ARP41-4 ug/mL Antitubercular compound ARP4?

0.447

Antimycin12.5-50 ug/mL Antimycin A?

0.432

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.505

PA_110-50 ug/mL Antitubercular compound PA-1?

0.399

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.412

PA8240.2-2 ug/mL PA-824?

-1.516

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.251

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.036

Verapamil50 uM Verapamil?

-0.079

mercaptoethanol2 mM 2-Mercaptoethanol?

0.481

methoxatin10-20 ug/mL Methoxatin?